A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous Urticaria

Summary

This multicenter, randomized, double-blind, placebo-controlled, parallel-group study will assess the efficacy and safety of additional quilizumab therapy in adult patients with Chronic Spontaneous Urticaria resistant to antihistamine treatment.

Timeline

Start

2013-12

Primary completion

2014-10

Completion

2014-10

Drugs

Indications